MicroTransponder is now Mobia Medical, and Vivistim’s look and feel will begin to reflect this change. You may notice some updates over the next few months, but it’s still the same Vivistim Therapy you know and trust. Learn more about our new name here.

MRI & Safety Information
Connect with Us

How Vivistim
Works
The Process
Patient
Testimonials
- Ambassadors
- Testimonials
News &
Resources
- Blog
- FAQs
- News
- Webinars
Professionals

Get Started

How Vivistim Works
The Process
Patient Testimonials
- Ambassadors
- Testimonials
News & Resources
Professionals
Get Started

Vivistim Therapy™ Offers a New Approach to Stroke Recovery and Rehabilitation

Post navigation

Previous: Vivistim technology helps stroke patients

Next: Vivistim Therapy™ Helping Chronic Ischemic Stroke Patients Improve Hand & Arm Function

Search

Want to know more?

Get Started Today

Dawson J, et al. Vagus nerve stimulation paired with rehabilitation for upper limb motor function after ischaemic stroke (VNS‑REHAB): a randomised, blinded, pivotal, device trial. Lancet, 2021:397(10284), 1545.
MicroTransponder data on file.
PMA P210007.
Francisco GE, et al. Vagus nerve stimulation paired with upper‑limb rehabilitation after stroke: two‑ and three‑year follow‑up from the pilot study. Arch Phys Med Rehabil, 2023:104(8), 1180.
Dawson J, et al. Vagus nerve stimulation paired with rehabilitation for upper limb motor impairment and function after chronic ischemic stroke: subgroup analysis of the randomized, blinded, pivotal, VNS‑REHAB device trial. Neurorehabilitation and Neural Repair, 2023:37(6), 367.
Meyers EC, et al. Vagus nerve stimulation enhances stable plasticity and generalization of stroke recovery. Stroke. 2018;49(3):710.

The MicroTransponder® Vivistim® Paired VNS™ System is intended to be used to stimulate the vagus nerve during rehabilitation therapy in order to reduce upper extremity motor deficits and improve motor function in chronic ischemic stroke patients with moderate to severe arm impairment. Do not use if you have had a bilateral or left cervical vagotomy. Risks may include, but are not limited to pain after surgery, hoarseness, bruising, swelling, coughing and throat irritation. Infection leading to explant is a risk associated with any device surgery. For full safety information, please see Instructions for Use and our Safety Information. Individual results may vary.